United Nations Climate Change
Our aim is to help our clients understand the potential opportunities and challenges that COP25 may have on their business.
Current directions in regulatory and intellectual property law in Canadian pharmaceutical cases
Publication | April 2016
Recent pharmaceutical cases in regulatory and intellectual property law have resulted in developments on several fronts, including:
- regulatory matters;
- patent validity and damages;
- Patented Medicines (Notice of Compliance) Regulations proceedings; and
- class actions.
In this paper, we review some of the most notable Canadian decisions from 2015 that will continue to impact the legal landscape for the pharmaceutical industry in Canada over the coming year.
Download the brochure here: 2015 Pharma in Brief (pdf 2.15MB)
Contact
Recent publications
Managing IMO 2020 Compliance: The Importance of Engagement Between Bunker Suppliers and Consumers
IMO 2020 is almost upon us. Readers are well aware of the impending switch to 0.5 percent fuel mandated by Annex VI of MARPOL which will cause an anticipated drop in HSFO demand, the potential hazards of new untested LSFO blends, the concerns around scrubber operations, the debate over open loop versus closed loop, and the myriad of other risks associated with the impending regulatory change.
Subscribe and stay up to date with the latest legal news, information and events...